We are live on ! Find out more
FCM

Frontier Capital Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 55.65%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$10.1B
AUM Growth
-$600M
Cap. Flow
-$306M
Cap. Flow %
-3.03%
Top 10 Hldgs %
15.42%
Holding
291
New
22
Increased
102
Reduced
155
Closed
12

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$79.4M
2
FTAI icon
FTAI Aviation
FTAI
+$74.1M
3
SM icon
SM Energy
SM
+$73.1M
4
ARRY icon
Array Technologies
ARRY
+$37.6M
5
EXP icon
Eagle Materials
EXP
+$37.2M

Sector Composition

Rank Sector Weight
1 Technology 22.99%
2 Industrials 22.02%
3 Healthcare 14.33%
4 Consumer Discretionary 12.79%
5 Financials 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
251
Euronet Worldwide
EEFT
$3.19B
$4.94M 0.05%
+47,767
New +$5.22M
FIVE icon
252
Five Below
FIVE
$11.6B
$4.85M 0.05%
44,475
-24,556
-36% -$3.4M
QGEN icon
253
Qiagen
QGEN
$8.62B
$4.82M 0.05%
113,985
-705
-0.6% -$30.9K
PATH icon
254
UiPath
PATH
$6.52B
$4.69M 0.05%
369,934
+290,351
+365% +$5.02M
PENG
255
Penguin Solutions Inc
PENG
$2.24B
$4.4M 0.04%
192,442
-229,674
-54% -$4.78M
WK icon
256
Workiva
WK
$3.45B
$4.29M 0.04%
+58,713
New +$4.62M
HXL icon
257
Hexcel
HXL
$7.97B
$4.24M 0.04%
+67,871
New +$4.55M
INCY icon
258
Incyte
INCY
$25.4B
$4.04M 0.04%
66,651
-540
-0.8% -$30.6K
BBIO icon
259
BridgeBio Pharma
BBIO
$16.4B
$3.76M 0.04%
148,368
-301,168
-67% -$8.23M
LESL icon
260
Leslie's
LESL
$8.33M
$3.24M 0.03%
38,613
-451
-1% -$43.9K
APLS
261
DELISTED
Apellis Pharmaceuticals
APLS
$2.98M 0.03%
77,561
-487
-0.6% -$22.1K
NET icon
262
Cloudflare
NET
$96B
$2.89M 0.03%
34,840
-31,755
-48% -$2.56M
CRSP icon
263
CRISPR Therapeutics
CRSP
$4.69B
$2.88M 0.03%
53,277
-48,821
-48% -$2.82M
ZS icon
264
Zscaler
ZS
$24.9B
$2.83M 0.03%
+14,708
New +$2.62M
JAZZ icon
265
Jazz Pharmaceuticals
JAZZ
$16.1B
$2.61M 0.03%
24,416
-8,830
-27% -$971K
PL icon
266
Planet Labs
PL
$6.94B
$2.43M 0.02%
1,308,961
-12,092
-0.9% -$23.2K
BE icon
267
Bloom Energy
BE
$46.6B
$1.47M 0.01%
119,911
-54,343
-31% -$693K
QTRX icon
268
Quanterix
QTRX
$159M
$620K 0.01%
46,898
-46,313
-50% -$774K
CTLT
269
DELISTED
CATALENT, INC.
CTLT
$604K 0.01%
+10,595
New +$591K
CAVA icon
270
CAVA Group
CAVA
$7.61B
$452K ﹤0.01%
4,874
-32
-0.7% -$2.47K
NI icon
271
NiSource
NI
$21.5B
$390K ﹤0.01%
+13,534
New +$382K
TOST icon
272
Toast
TOST
$18.9B
$370K ﹤0.01%
14,362
-90
-0.6% -$2.18K
UA icon
273
Under Armour Class C
UA
$2.95B
$364K ﹤0.01%
55,727
-359,663
-87% -$2.38M
CRBG icon
274
Corebridge Financial
CRBG
$14.3B
$311K ﹤0.01%
+10,689
New +$308K
LKQ icon
275
LKQ Corp
LKQ
$6.72B
$259K ﹤0.01%
+6,230
New +$279K

Similar funds

Frontier Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Frontier Capital Management held 291 positions worth $10.1B, down 5.6% from $10.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Frontier Capital Management withdrew a net $306M in Q2 2024, closing 12 positions and reducing 155 holdings. Its most notable exit was Lam Research, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Frontier Capital Management opened a new position in DraftKings worth $43.9M.

  • Frontier Capital Management's largest Q2 2024 buy was DraftKings: 1,150,171 shares worth $43.9M.
  • Frontier Capital Management added most to Darling Ingredients in Q2 2024, an estimated $52.6M increase.
  • Frontier Capital Management's biggest Q2 2024 reduction was XPO, cutting an estimated $79.4M.
  • Frontier Capital Management fully exited Lam Research in Q2 2024, selling an estimated $33.8M.
  • Frontier Capital Management's ten largest holdings make up 15% of its $10.1B portfolio in Q2 2024.
  • Frontier Capital Management opened 22 new positions and closed 12 in Q2 2024.
  • Frontier Capital Management's portfolio value fell 5.6% quarter-over-quarter to $10.1B.

Based on Frontier Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.